Carisma: Carisma's lifeline dissipates as reverse merger plans fall through, Moderna cuts ties.
After Carisma Therapeutics laid off 95% of its team earlier this year, a Hail Mary merger proposal with another biotech has fallen through.
Read full article »
Carisma is a Pennsylvania-based biopharmaceutical company that researches and develops CAR-macrophage immunotherapies for the treatment of cancer.
Read more